 Bilirubin
"Bilirubin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bile pigment that is a degradation product of HEME.
| Descriptor ID |
D001663
|
| MeSH Number(s) |
D03.383.129.578.840.249.184 D03.549.909.249.184 D04.345.783.249.184 D23.767.193.184
|
| Concept/Terms |
Bilirubin, Calcium Salt- Bilirubin, Calcium Salt
- Calcium Salt Bilirubin
- Salt Bilirubin, Calcium
- Calcium Bilirubinate
- Bilirubinate, Calcium
|
Below are MeSH descriptors whose meaning is more general than "Bilirubin".
Below are MeSH descriptors whose meaning is more specific than "Bilirubin".
This graph shows the total number of publications written about "Bilirubin" by people in this website by year, and whether "Bilirubin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1981 | 0 | 2 | 2 | | 1983 | 1 | 1 | 2 | | 1985 | 1 | 2 | 3 | | 1987 | 1 | 2 | 3 | | 1990 | 0 | 3 | 3 | | 1991 | 2 | 4 | 6 | | 1992 | 1 | 1 | 2 | | 1993 | 2 | 1 | 3 | | 1994 | 1 | 2 | 3 | | 1995 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 0 | 3 | 3 | | 1998 | 0 | 4 | 4 | | 1999 | 1 | 1 | 2 | | 2000 | 0 | 5 | 5 | | 2001 | 1 | 5 | 6 | | 2002 | 1 | 3 | 4 | | 2003 | 0 | 1 | 1 | | 2004 | 1 | 2 | 3 | | 2005 | 0 | 1 | 1 | | 2007 | 2 | 2 | 4 | | 2009 | 1 | 4 | 5 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 1 | 1 | | 2012 | 0 | 2 | 2 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 | | 2015 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 1 | 2 | | 2020 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bilirubin" by people in Profiles.
-
Sakamaki A, Takamura M, Sakai N, Watanabe Y, Arao Y, Kimura N, Setsu T, Abe H, Yokoo T, Kamimura H, Tsubata S, Waguri N, Ishikawa T, Kawai H, Sugitani S, Sato T, Funakoshi K, Watanabe M, Igarashi K, Kamimura K, Tsuchiya A, Aoyagi Y, Terai S. Longitudinal increase in albumin-bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis. PLoS One. 2022; 17(2):e0263464.
-
Cotter TG, Wang J, Peeraphatdit T, Sandikçi B, Ayoub F, Kim G, Te H, Jeevanandam V, Sabato D, Charlton M. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes. Hepatology. 2021 04; 73(4):1464-1477.
-
Bhavani SV, Huang ES, Verhoef PA, Churpek MM. Novel Temperature Trajectory Subphenotypes in COVID-19. Chest. 2020 12; 158(6):2436-2439.
-
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. N Engl J Med. 2017 11 16; 377(20):1930-1942.
-
Nassin ML, Vergilio JA, Heeney MM, LaBelle JL. Neonatal anemia: Revisiting the enigmatic pyknocyte. Am J Hematol. 2017 Jul; 92(7):717-721.
-
Toesca DAS, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. Pract Radiat Oncol. 2017 May - Jun; 7(3):173-182.
-
Schumacher KR, Gossett J, Guleserian K, Naftel DC, Pruitt E, Dodd D, Carboni M, Lamour J, Pophal S, Zamberlan M, Gajarski RJ. Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis. J Heart Lung Transplant. 2015 Sep; 34(9):1169-76.
-
van Slambrouck CM, Chang A. Response to Heyman et al. and Bredewold et al. Kidney Int. 2014 Feb; 85(2):480.
-
Elsoueidi R, Craig J, Mourad H, Richa EM. Safety and efficacy of FOLFOX followed by cetuximab for metastatic colorectal cancer with severe liver dysfunction. J Natl Compr Canc Netw. 2014 Feb; 12(2):155-60.
-
Uriel N, Han J, Morrison KA, Nahumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayama H, Thomas S, Naka Y, Jorde UP. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant. 2014 Jan; 33(1):51-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|